Business Standard

Global community can tap India's Covid vaccine capacity, say firms

Bharat Biotech MD Krishna Ella said India now has four BSL-4 containment facilities, equal to that of the UK.


Indian firms have built huge capacities to make Covid-19 vaccines.

Sohini Das Mumbai
Indian vaccine makers feel the global community can tap India’s massive jab production capacities created during the Covid-19 pandemic.

The world produced 11 billion doses of the Sars-CoV-2 vaccine last year. This is almost threefold higher than the total vaccine production capacity globally for all jabs put together, which was below 4 billion doses a year. Is this leading to vaccine oversupply of a particular kind?

While oversupply is true for some countries, said Mahima Datla, managing director (MD) of Corbevax vaccine maker Biological E, it is not true for African countries.

“From the business side, one can say if companies were only

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 25 2022 | 6:10 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to